Ani pharmaceuticals inc (ANIP)
Income statement / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Sep'10Jun'10
Licensing revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

Royalty revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

392

335

272

0

0

0

-

Net Revenues

203,434

206,547

215,703

215,069

207,980

201,576

191,740

189,201

186,697

176,842

167,761

158,122

144,695

128,622

108,452

89,899

78,078

76,322

79,324

76,739

63,870

55,970

45,465

35,914

35,419

30,082

29,584

26,784

25,819

20,371

10,451

5,597

492

435

372

0

0

0

-

Operating Expenses:
Cost of sales (excluding depreciation and amortization)

70,233

63,154

65,492

66,095

67,056

73,024

73,337

78,810

83,339

79,032

75,492

71,083

61,756

48,780

35,414

22,005

13,351

12,692

12,825

12,626

11,602

11,473

10,485

10,134

10,188

9,974

9,610

9,019

0

-

0

0

-

-

-

-

-

-

-

Salaries and benefits

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

Freight

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

Research and development

21,777

19,806

18,610

18,295

17,659

15,388

14,557

12,524

9,554

9,070

6,554

4,961

3,558

2,906

3,432

3,206

3,437

2,874

2,781

2,849

2,705

2,678

2,635

2,206

1,792

1,712

-3,196

-3,502

-3,729

1,158

12,243

23,594

34,501

44,182

47,196

44,354

0

0

0

Selling, general, and administrative

56,242

55,843

55,205

52,617

48,391

44,063

39,572

35,825

33,243

31,580

30,064

28,970

29,218

27,829

25,915

24,386

22,309

21,156

20,443

19,101

18,983

17,935

16,619

16,042

17,781

16,388

18,480

16,257

9,999

9,521

5,726

6,144

7,219

6,981

6,792

6,657

0

0

0

Depreciation and amortization

39,692

44,612

43,734

42,809

41,650

33,742

32,078

30,629

29,417

27,928

26,718

25,585

24,440

22,343

18,642

14,723

10,182

6,900

6,071

5,211

4,502

3,878

3,032

2,227

1,668

1,110

925

687

681

567

345

237

137

148

159

166

0

0

0

Cortrophin pre-launch charges

0

-

0

-

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total Operating Expenses

199,327

190,196

183,236

179,816

174,756

166,217

160,447

158,691

156,456

148,513

145,513

137,284

125,657

108,543

83,403

64,320

49,279

43,622

42,120

39,787

37,792

35,964

32,771

30,609

31,429

29,184

25,635

23,852

18,526

20,413

25,394

33,362

41,908

51,361

54,148

51,177

0

0

0

Operating (Loss)/Income

4,107

16,351

32,467

35,253

33,224

35,359

31,293

30,510

30,241

28,329

22,248

20,838

19,038

20,079

25,049

25,579

28,799

32,700

37,204

36,952

26,078

20,006

12,694

5,305

3,990

898

-2,769

-2,992

0

-

0

0

-

-

-

-

-

-

-

Other Expense, net
Interest expense, net

-11,644

-12,966

-13,722

-14,154

-14,478

-14,758

-14,158

-13,442

-12,737

-12,035

-11,868

-11,672

-11,477

-11,327

-11,236

-11,146

-11,065

-11,008

-9,040

-6,264

-3,512

-787

-173

-183

-560

-467

339

420

1,295

1,327

871

962

633

681

688

688

0

0

0

Convertible note fair value adjustment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-2,594

-23

-1,826

-2,670

0

0

0

Investment impairment charge

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

Other income /(expense), net

-88

-228

-596

-543

-619

-550

-74

1

12

55

15

-101

-94

-74

-30

-37

-25

41

128

238

199

160

103

169

-226

-305

-427

-625

0

-

0

0

-

-

-

-

-

-

-

(Loss)/Income Before Benefit/(Provision) for Income Taxes

-7,625

3,157

18,149

20,556

18,127

20,051

17,061

17,069

17,516

16,349

10,395

9,065

7,467

8,678

13,783

14,396

17,709

21,733

28,292

30,926

22,765

19,379

12,810

5,477

3,390

126

-3,744

-4,667

0

-

0

0

-

-

0

-

-

-

-

Benefit/(provision) for income taxes

-6,306

-2,937

1,790

3,055

4,434

4,557

16,626

16,951

17,494

17,425

2,922

3,769

3,727

4,744

5,893

4,490

5,357

6,358

-5,212

-4,765

-6,992

-9,368

1,680

52

185

20

-82

0

0

-

0

0

-

-

-

-

-

-

-

Net Income from Continuing Operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

106

-3,660

-4,666

0

-

0

0

-

-

-

-

-

-

-

Discontinued Operation
Gain on discontinued operation, net of $38 provision for income taxes in the year ended December 31, 2013

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

0

0

-

-

-

-

-

-

-

Net (Loss)/Income

-1,366

6,094

16,359

17,501

13,693

15,494

435

118

22

-1,076

7,473

5,296

3,740

3,934

7,890

9,906

12,352

15,375

33,504

35,691

29,757

28,747

11,175

5,620

3,400

301

-3,509

-4,664

0

-

0

0

-

-

-

-

-

-

-

Net Income from Continuing Operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

106

-3,660

-4,666

0

-

0

0

-

-

-

-

-

-

-

Preferred stock dividends

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

4,975

7,501

8,640

0

-

0

0

-

-

-

-

-

-

-

Income/(Loss) from Continuing Operations Attributable to Common Stockholders and Participating Securities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-6,424

-575

-8,496

-20,923

-30,750

-44,622

-51,608

0

0

0

-

-

Other income

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

Interest income

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

7

8

0

0

0

-

-

Continuing operations (in dollars per share)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0.11

-

-

-

-

-

-

-

-

-

-

-

-

Discontinued operation (in dollars per share)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0.02

-

-

-

-

-

-

-

-

-

-

-

-

Basic (Loss)/Earnings Per Share

-0.59

-0.40

0.32

0.55

0.04

0.45

0.43

0.24

0.19

-0.83

0.41

0.23

0.10

-0.10

0.22

0.10

0.12

0.25

0.40

0.31

0.38

1.90

0.59

-0.21

0.33

4.98

0.13

-6.03

0.00

-

-

-

-

-

-

-

-

-

-0.17

Continuing operations (in dollars per share)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0.11

-

-

-

-

-

-

-

-

-

-

-

-

Discontinued operation (in dollars per share)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0.02

-

-

-

-

-

-

-

-

-

-

-

-

Diluted (Loss)/Earnings Per Share

-0.59

-0.39

0.32

0.53

0.04

0.46

0.42

0.23

0.19

-0.82

0.40

0.23

0.10

-0.10

0.22

0.10

0.12

0.24

0.39

0.31

0.38

1.88

0.59

-0.21

0.33

4.98

0.13

-6.03

0.00

-

-

-

-

-

-

-

-

-

-0.17

Weighted average number of common and common equivalent shares outstanding:
Basic Weighted-Average Shares Outstanding

11,902

11,887

11,879

11,851

11,747

11,734

11,706

11,679

11,589

11,562

11,553

11,546

11,527

11,518

11,465

11,402

11,395

11,426

11,384

11,344

11,326

11,305

11,235

11,233

9,991

-10,612

9,480

1,153

0

-

-

-

-

-52,244

17,406

15,664

84,764

71,194

64,607

Diluted Weighted-Average Shares Outstanding

11,902

11,983

12,085

12,269

11,823

11,789

11,804

11,789

11,706

11,191

11,677

11,667

11,653

11,637

11,625

11,541

11,489

11,554

11,563

11,549

11,562

11,676

11,302

11,233

10,001

-10,612

9,480

1,153

0

-

-

-

-

-52,244

17,406

15,664

84,764

-

-

Continuing operations (in dollars per share)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-1,295.82

-1,644.86

-

-

-

-

-

-

-

Discontinued operation (in dollars per share)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0.72

0.00

-

-

-

-

-

-

-

Interest income

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

NET LOSS

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

Basic and Diluted Income/(Loss) Per Share (in dollars per share)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2,940.49

-1,295.10

-1,644.86

-0.53

-

-0.73

-0.96

-0.20

-0.16

-

Basic and Diluted Weighted-Average Shares Outstanding (in shares)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-19,380

2

0

19,377

-

-

-

-

-

-